Back to search
FDAFDA · Food and drugs·Recall number D-1617-2020

Nature Throid, 1.25 Grain (81.25 mg) Thyroid USP [Liothyronine (T3) 11.25 mcg, Levothyroxine (T4) 47.5 mcg], 100-count bottles, Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024, NDC 64727-3303-1

Published September 23, 2020 · Recall initiated: August 25, 2020

Summary

FDA records drug Class I recall D-1617-2020, published September 23, 2020 and initiated August 25, 2020. Recalling firm: RLC Labs Inc.; Status: Terminated; Reported quantity: N/A; Lot: Lot #: 109032, Exp. Date 10/2022. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: FDA analysis found product to be subpotent

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RLC Labs Inc.
Distributor
Nationwide in the United States
Lot
Lot #: 109032, Exp. Date 10/2022
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nature Throid, 1.25 Grain (81.25 mg) Thyroid USP [Liothyronine (T3) 11.25 mcg, Levothyroxine (T4) 47.5 mcg], 100-count bottles, Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024, NDC 64727-3303-1 recalled?

Yes. FDA published recall D-1617-2020 on September 23, 2020. Reported hazard: Subpotent Drug: FDA analysis found product to be subpotent

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail